Cancer Prevention News and Research

RSS

Research findings may explain marked racial disparity in deaths from triple negative breast cancer

Different activity in two molecular networks could help explain why triple negative breast cancers tend to be more aggressive in African American (AA) women compared with white American (WA) women, a new study led by Johns Hopkins Kimmel Cancer Center researchers suggests.

15 Mar 2022

Mason scientists receive DOD funding for breast cancer prevention and treatment research

George Mason University College of Science announced a $1.57 million dollar grant from the Department of Defense to fund a transformative approach for breast cancer treatment developed by scientists in Mason's Center for Drug Discovery for Rare Diseases.

15 Mar 2022

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna.

14 Mar 2022

New fluorescent label provides a clearer picture of how DNA architecture is disrupted in cancer cells

Researchers have developed a new fluorescent label that gives a clearer picture of how DNA architecture is disrupted in cancer cells. The findings could improve cancer diagnoses for patients and classification of future cancer risk.

4 Mar 2022

Study provides insight into what causes therapy failure in patients with myelodysplastic syndromes

Researchers from The University of Texas MD Anderson Cancer Center discovered that treatment resistance in patients with myelodysplastic syndromes (MDS) is caused by two distinct classes of stem cells and identified possible therapeutic approaches that target these cells.

3 Mar 2022

UH researcher receives $2 million to develop drugs for traditionally undruggable targets in cancer

With a $2 million recruitment grant from the Cancer Prevention and Research Institute of Texas, a University of Houston researcher is setting up a lab to develop drugs that will work on traditionally undruggable targets in cancer.

2 Mar 2022

MUSC study sheds light on better ways to prevent and treat colorectal cancer

An MUSC Hollings Cancer Center study sheds light on better ways to prevent and treat colorectal cancer, which often is found at advanced stages when it's much harder to treat.

28 Feb 2022

Human nose organoids provide better understanding of the first steps toward SARS-CoV-2 infection

Preclinical models that recapitulate aspects of human airway disease are essential for the advancement of novel therapeutics and vaccines.

16 Feb 2022

New drug effective in patients with muscle-invasive bladder cancer ineligible for cisplatin chemotherapy

Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in patients with muscle-invasive bladder cancer (MIBC) not eligible for cisplatin chemotherapy.

15 Feb 2022

U-M researchers measure out-of-pocket costs for follow-up tests after free cancer screening

With the White House putting cancer prevention and early treatment squarely in the sights of its renewed Cancer Moonshot initiative, recent University of Michigan research offers insights that policymakers could use to ensure more cancers are diagnosed earlier and reduce inequalities.

15 Feb 2022

Researchers shows how ΔNp63 protein contributes to lung cancer development

Lung cancer is the second most common cancer in the U.S. and the No. 1 cause of cancer related death. Despite considerable progress in treatment options, most lung cancer patients have extremely poor outcomes with an average five-year survival rate of 21.7%.

12 Feb 2022

Cancer patients undergoing active treatment may be more vulnerable to COVID-19-related misinformation

Cancer patients undergoing active treatment were more likely to believe misinformation related to COVID-19 than those without a history of cancer, according to a new study led by researchers at Virginia Commonwealth University.

12 Feb 2022

New collaborative center aims to address health disparities in multiple chronic diseases

A multi-institutional group in New York City has united to address health disparities in multiple chronic diseases through a new collaborative center.

11 Feb 2022

30-year-old cancer drug could get another shot, study says

A study by Virginia Commonwealth University Massey Cancer Center researchers published in today's print edition of Molecular Cancer Therapeutics shows that triplatin is effective against triple negative breast cancer, which is the most aggressive form of breast cancer and has few targeted therapies.

9 Feb 2022

World Cancer Day: MD Anderson commits to advance excellence in patient care, research, and prevention

The University of Texas MD Anderson Cancer Center celebrates World Cancer Day, Feb. 4, in honor of the global initiative to end cancer.

4 Feb 2022

Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests

A new study by researchers at Yale Cancer Center shows using current standard human epidermal growth factor receptor 2 (HER2) assays as a diagnostic test may result in a mis-assignment of patients for treatment for breast cancer with a promising new drug.

3 Feb 2022

Cancer Prevention News and Research

Research findings may explain marked racial disparity in deaths from triple negative breast cancer

Mason scientists receive DOD funding for breast cancer prevention and treatment research

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

New fluorescent label provides a clearer picture of how DNA architecture is disrupted in cancer cells

Study provides insight into what causes therapy failure in patients with myelodysplastic syndromes

UH researcher receives $2 million to develop drugs for traditionally undruggable targets in cancer

MUSC study sheds light on better ways to prevent and treat colorectal cancer

Human nose organoids provide better understanding of the first steps toward SARS-CoV-2 infection

New drug effective in patients with muscle-invasive bladder cancer ineligible for cisplatin chemotherapy

U-M researchers measure out-of-pocket costs for follow-up tests after free cancer screening

Researchers shows how ΔNp63 protein contributes to lung cancer development

Cancer patients undergoing active treatment may be more vulnerable to COVID-19-related misinformation

New collaborative center aims to address health disparities in multiple chronic diseases

30-year-old cancer drug could get another shot, study says

World Cancer Day: MD Anderson commits to advance excellence in patient care, research, and prevention

Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests

CECR2 gene inhibition prevents triple-negative breast cancer from metastasizing, study shows

Novel test uses cervical screening samples to detect breast and ovarian cancer

Damon Runyon Cancer Research Foundation announces newest cohort of Fellows and Breakthrough Scientists

Rural adults more likely to think fatalistically about cancer than urban residents

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News